Ruey-Long Hong

Years Active: 2019-2022
Publications (10 Years): 5

National Taiwan University Hospital

Graduate Institute of Clinical Medicine, National Taiwan University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Taiwan University Hospital Jul 01 1984

Taiwan

Visiting staff :: Oncology

Education History

Graduate Institute of Clinical Medicine, National Taiwan University Sep 01 1990 - Jun 30 1996

Taiwan

PHD

Publications

Yu-Ju Tseng, Chun-Nan Chen, Ruey-Long Hong, Woon-Man Kung, Abel Po-Hao Huang
Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Olfactory Neuroblastoma. Brain sciences 13 (1) (2022)
Yu-Ju Tseng, Chun-Nan Chen, Ruey-Long Hong, Woon-Man Kung, Abel Po-Hao Huang
Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Olfactory Neuroblastoma. Brain sciences 13 (1) (2022)
Tom Wei-Wu Chen, Chia-Lang Hsu, Ruey-Long Hong, Jen-Chieh Lee, Koping Chang, Chih-Wei Yu, San-Chi Chen, Jhe-Cyuan Guo, Mei-Lu Chen, Meng-Chi Hsu, Ting-Fang Kung, Ann-Lii Cheng, Chueh-Chuan Yen
A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
Yu-Ju Tseng, Chun-Nan Chen, Ruey-Long Hong, Woon-Man Kung, Abel Po-Hao Huang
Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Olfactory Neuroblastoma. Brain sciences 13 (1) (2022)
Po-Chun Peng, Ruey-Long Hong, Tsuimin Tsai, Chin-Tin Chen
Co-Encapsulation of Chlorin e6 and Chemotherapeutic Drugs in a PEGylated Liposome Enhance the Efficacy of Tumor Treatment: Pharmacokinetics and Therapeutic Efficacy. Pharmaceutics 11 (11) (2019)

Ruey-Long Hong.css-eqlu8i{font-size:small;padding-left:4px;}